PepGen Inc. (PEPG)
NASDAQ: PEPG · Real-Time Price · USD
5.73
+0.22 (3.99%)
At close: Feb 11, 2026, 4:00 PM EST
5.39
-0.34 (-5.93%)
After-hours: Feb 11, 2026, 7:35 PM EST
PepGen Market Cap
PepGen has a market cap or net worth of $393.93 million as of February 11, 2026. Its market cap has increased by 549.74% in one year.
Market Cap
393.93M
Enterprise Value
247.70M
1-Year Change
549.74%
Ranking
Category
Stock Price
$5.73
Market Cap Chart
Since May 6, 2022, PepGen's market cap has increased from $288.65M to $393.93M, an increase of 36.47%. That is a compound annual growth rate of 8.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 378.80M | -15.36% |
| Dec 31, 2025 | 447.55M | 262.28% |
| Dec 31, 2024 | 123.54M | -23.71% |
| Dec 29, 2023 | 161.93M | -48.75% |
| Dec 30, 2022 | 315.96M | 9.46% |
| May 6, 2022 | 288.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tectonic Therapeutic | 411.95M |
| Niagen Bioscience | 409.26M |
| Immutep | 409.10M |
| Benitec Biopharma | 399.07M |
| Entrada Therapeutics | 396.99M |
| Monopar Therapeutics | 396.88M |
| Absci | 390.97M |
| NovaBridge Biosciences | 390.84M |